Get started

Stocktrading

AMF.N000050DMA (Green line) acting as a resistance line & 23 will be the strong support level in upcoming days. Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
CSELK:AMF.N0000Long
by rukshan2102
🗺️NVIDIA Roadmap🗺️🚀➕20%🚀🔔Today, I want to analyze NVIDIA stock for you because I think it still has the potential to increase in price, and also, in NVIDIA 's previous rally, AI tokens had a good rise. 💡The main reason for Nvidia's growth is the company's leadership in the field of Artificial Intelligence(AI) chips . The market value of this company crossed the one trillion dollar mark less than a year ago. Nvidia now has a higher market value than the well-known companies Amazon and Google . 💡 Nvidia's earnings report that was published exceeded expectations so that Nvidia was able to make $26 billion in profits in the first 3 months of this year, which is really great. 💡Profitability was 5.3% higher than forecasts , and Nvidia made a profit of $6.12 Earnings per Share(EPS) . 💡Nvidia forecasted $28 billion in revenue for the fiscal second quarter , with a margin of error of 2% . 💡Soon the price of each stock will be divided into 10 units. For each stock of the price break, $0.01 is distributed, which represents 150% growth from the previous period. 💡 Artificial Intelligence Tokens have not yet shown their progress, but it is better to keep an eye on them. BINANCE:FETUSDT _ BINANCE:NEARUSDT _ BINANCE:RNDRUSDT _ BINANCE:GRTUSDT _ BINANCE:TAOUSDT _ BINANCE:INJUSDT _ BINANCE:THETAUSDT -------------------------------------------------------------------------------------------- 📊Now let's take a look at the NVIDIA chart . ✅ NVIDIA managed to break the 🔴 Resistance zone($974_$924) 🔴 by Breakaway Gap . 📈In terms of Classic Technical Analysis , NVIDIA has managed to form a Bullish Long Island Pattern , and this pattern is one of the continuing patterns and will be a sign of the continuation of NVIDIA's upward trend . 🌊According to the theory of Elliott Waves , NVIDIA is completing the main wave 5 and it is very likely that the main wave 5 will finish in the 🟡 Potential Reversal Zone(PRZ)($1,305_$1,138) 🟡. 🔔I expect that NVIDIA will continue to grow at least 🚀➕20%🚀 more, although minor corrections are also possible. NVIDIA Analyze (NVDAUSD), Daily time frame ⏰. Do not forget to put Stop loss for your positions (For every position you want to open). Please follow your strategy; this is just my Idea, and I will gladly see your ideas in this post. Please do not forget the ✅' like '✅ button 🙏😊 & Share it with your friends; thanks, and Trade safe.
NASDAQ:NVDALong
by pejman_zwin
1
TATAMOTORS Support Breach: Bullish Opportunity!🚨 Stock Update: TATAMOTORS 🚨 Date : 16-05-2024 TATAMOTORS breached major support today due to heavy selling pressure and closed at 936.40. I expect the stock to consolidate for a while, which presents a good opportunity to accumulate. I'm bullish on this stock and plan to buy small quantities below 930 with a stop loss at the next support level (872.10) . My initial target is 1069 . Stay tuned for important updates and adjustments. Upvote and follow for regular updates! 📈💼
NSE:TATAMOTORSLong
by IndexAce
GE HealthCare | GEHCGE Healthcare aka GEHC is a renowned global medical technology, pharmaceutical diagnostics, and digital solutions company that aims to revolutionize healthcare by eliminating limits. With a diverse portfolio of innovative products, services, and solutions, GEHC empowers healthcare professionals to make informed decisions quickly and improve patient care across the entire healthcare continuum. This article delves into the key aspects of GE Healthcare, including its business segments, macro trends driving growth, management incentives, financial performance, competitors, and valuation. GE Healthcare operates in four business segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. These segments cater to healthcare providers and researchers worldwide, offering a wide range of products and solutions that enhance clinical decision-making and patient outcomes. The company's revenue streams come from the sale of medical devices, consumable products, services, and digital solutions. By focusing on customer-driven innovation, industry-leading service capabilities, and integrated digital solutions, GEHC continually improves the performance, quality, and customer experience of its offerings. GE Healthcare benefits from several macro trends that are shaping the healthcare industry. The growing adoption of precision health, fueled by advancements in genomics, personalized medicine, and targeted therapies, presents opportunities for GEHC to develop tailored solutions. The global precision medicine market is projected to reach $278.3 billion by 2027, with a CAGR of 10.5%. Additionally, the market for genomic testing is expected to reach $30.9 billion by 2027, growing at a CAGR of 14.7%. The digitization of healthcare through AI and machine learning enables the analysis of vast amounts of patient data for more accurate diagnoses and treatment decisions. The global healthcare artificial intelligence market is predicted to reach $31.3 billion by 2025, growing at a CAGR of 41.5%. Furthermore, increasing demand for healthcare services driven by demographic trends and improving access to healthcare in emerging markets further support GEHC's growth trajectory. With personalized medicine estimated to have a market value of $3,168.0 billion by 2027, GEHC is well positioned to leverage these trends and provide innovative solutions to meet the evolving needs of the healthcare industry (Sources: Grand View Research, Fortune Business Insights, Allied Market Research, MarketsandMarkets). GEHC CEO, Peter J. Arduini, has improved incentives in place to drive the company's performance. With an amended offer letter, Arduini's base salary increased to $1,250,000, accompanied by an annual target bonus of 150% of his base salary and an annual long-term incentive grant target of $11,875,000 starting in 2023. These incentives provide a strong motivation for Arduini to lead GEHC's growth and success, enhancing shareholder value. In 2022, GEHC reported total revenue of $18.34 billion, representing a favorable increase compared to the previous year. Although the profitability declined in the final quarter, the company's operating cash flow and adjusted EBIT margin showed positive trends. GEHC guided organic revenue growth of 5% to 7% for 2023, along with higher adjusted EBIT margin and EPS ranges. The company's commitment to achieving a free cash flow conversion target of 85% or more further reinforces its positive financial outlook. GEHC faces competition from prominent players in the medical technology industry, including Philips Healthcare, Draeger, Mindray, Masimo, and Baxter. In specific segments, GEHC competes with Siemens Healthineers, Canon, Fujifilm, Carestream, Hologic, and other companies. Despite competition, GEHC's comprehensive product portfolio, customer-focused approach, and commitment to innovation position it well in the market. GE Healthcare stands out from its competitors in the healthcare sector due to its robust portfolio of cutting-edge products and data-driven solutions. The company's commitment to innovation and advanced technologies enables it to offer unique offerings that address the evolving needs of the industry. One key area where GEHC excels is precision health. Leveraging advancements in genomics, personalized medicine, and targeted therapies, GEHC develops tailored solutions that provide precise and effective treatments for patients. For example, its innovative imaging technologies, such as magnetic resonance imaging (MRI) and computed tomography (CT), enable high-resolution visualization of anatomical structures, aiding in the accurate diagnosis and monitoring of various medical conditions. Moreover, GEHC is at the forefront of the digital revolution in healthcare. By harnessing the power of artificial intelligence (AI) and machine learning, GEHC's products analyze vast amounts of patient data to deliver more accurate diagnoses and treatment decisions. For instance, its AI-powered imaging software can detect and analyze anomalies in medical images, helping clinicians detect diseases at an early stage and enhance treatment outcomes. This data-driven approach not only improves patient care but also increases operational efficiency in healthcare facilities. GEHC's commitment to delivering innovative solutions is further reflected in its diverse product offerings. The company provides a wide range of medical devices, including ultrasound systems, patient monitors, anesthesia machines, and diagnostic imaging equipment. These products are designed to meet the unique needs of healthcare providers and patients, empowering clinicians to make informed decisions and improving patient outcomes. Based on a valuation analysis using trading multiples of similar companies, GEHC's value is estimated to range from $55 billion to $81 billion. Taking the midpoint of this range, the company's estimated enterprise value (EV) is $64 billion, suggesting a potential stock price of $125. This valuation indicates a significant upside potential of at least 66% within 18 to 24 months from the current price. With its strong market position, growth opportunities, and commitment to advancing healthcare, GEHC presents an attractive investment prospect. GE Healthcare is a leading global medical technology and digital solutions company with a clear mission to transform healthcare. With its diverse portfolio of products, services, and solutions, GEHC is well-positioned to capitalize on the growing demand for precision health, digitization, and improved access to healthcare. The company's financial performance, management incentives, and competitive landscape further support its growth potential. Considering the estimated valuation, GE Healthcare's stock price has the potential to increase significantly in the next 1.5 to 2 years, offering investors an opportunity for substantial returns.
NASDAQ:GEHCLong
by moonypto
Watts Water Technologies (WTS) Analysis Industry Leadership: Watts Water Technologies NYSE:WTS is making significant strides in the plumbing and water filtration industry. CEO Robert J. Pagano Jr. reported record sales, operating earnings, and EPS in Q1, leading to an increased full-year outlook for 2024. Strategic Acquisitions: The integration of recent acquisitions—Bradley Corporation, Josam Company, and Enware—is progressing well. These acquisitions are set to drive revenue growth by expanding WTS's market share into new areas. The $303 million Bradley acquisition is particularly impactful, enhancing market share and offering synergistic growth opportunities. Financial Strength: WTS's strong balance sheet and robust cash flow support continued strategic investments, shareholder returns, and long-term execution. Investment Outlook: Bullish Outlook: We are bullish on WTS above the $184.00-$185.00 range. Upside Potential: With an upside target set at $315.00-$320.00, investors should monitor the successful integration of acquisitions and sustained financial performance as key growth drivers. 📊🚰 Keep an eye on Watts Water Technologies for promising investment opportunities! #WTS #WaterTechnology 🌊📈
NYSE:WTSLong
by Richtv_official
ASIR.N0000📈 Stock ASIR closed at 23.9 on 31/05/2024 🔹 Resistance Level: 25 🔹 200 EMA: 24.8 🔹 Last Friday's candle: Pin Bar The recent pin bar candle suggests a potential reversal, with the 200 EMA acting as a significant resistance level at 24.8. Keep an eye on this stock as it approaches the 25 resistance level. Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
CSELK:ASIR.N0000Long
by rukshan2102
SMCI: Strong accumulation. Buy it while you can.Super Micro Computer is neutral on its 1W technical outlook (RSI = 53.442, MACD = 90.250, ADX = 30.355) and the reason is that below the 1W MA50 it is expanding the new Cycle's accumulation phase. Every Cycle experienced this accumulation under the 1W MA50, sometimes shorter others longer. Technically, on a two year basis, every time it crossed under the 1W MA50 and consolidated, the stock was a buy opportunity. The trigger to buy is given on the S1 level (50.60) of the 1W RSI. The last two Cycles grew by at least +400% from the first low that followed the crossing under the 1W MA50. Consequently we turn long on SMCI, aiming for another +400% rise (TP = 3,300). ## If you like our free content follow our profile to get more daily ideas. ## ## Comments and likes are greatly appreciated. ##
NASDAQ:SMCILong
by InvestingScope
NIFTY 660+ Points GainAfter a massive week of 660+ points gain, NIFTY has given a SHORT opportunity yesterday. Days of volatility, guys! BIG money. Everybody is talking about the co-relation of election results. And why not, market being driven by fundamentals in full power and josh. A big move is still pending, I dont know if thats gonna happen on Monday 3rd June, 4th June or 5th June. There is a possibility of big gap-ups and gap-downs on these days, specifically. So, BTST traders, you better watch out and be careful. Risk management is key. Also, position sizing needs to be watched. You would not want to go in big with a hope to capture big move, only to witness a rude reversal. NO POSITION IS ALSO A POSITION! So, be careful, and enjoy the fireworks, gonna start any time now.
NSE:NIFTY
by ProfitsNinja
S&P 500 (US500):🔴Bearish or bullish...?!🔴By examining the weekly and 4-hour charts, we can determine the price was heavily pushed down after creating the all-time high. I am not bearish for the long-term on the S&P500, but for now, I think the price can have a bearish reaction to the bearish breaker block and move down at least till the previous week's low, then we should study the price to find out the next move. 💡Wait for the update! 🗓️27/05/2024 🔎 DYOR 💌It is my honor to share your comments with me💌
CME_MINI:ES1!Short
by VahidTradingCR
1
💻💡 GigaCloud Technology (GCT) Analysis 📊🔍Strategic Acquisitions: GigaCloud Technology NASDAQ:GCT , a B2B e-commerce solutions provider, recently completed two significant acquisitions: Noble House Home Furnishings' assets for $85 million and Wondersign, a digital signage company, for $10 million. These strategic moves are expected to significantly enhance GigaCloud's revenue and margins. Leadership Highlights: CEO Larry Wu emphasized the company's adaptability and strong profitability. Notably, GigaCloud Marketplace's gross merchandise volume surged by 40.8% year-over-year to $684.8 million. Active buyers increased by 9.6%, and spend per buyer rose by 28.5% to $148,793. Investment Outlook: Bullish Outlook: We hold a bullish stance on GCT above the $29.00-$30.00 range. Upside Potential: With a target set at $58.00-$60.00, investors should closely monitor key performance indicators such as growth in merchandise volume and the successful integration of acquisitions. 📈💻 Stay informed about GigaCloud Technology's progress for potential investment opportunities! #GCT #EcommerceSolutions 📊🔍
NASDAQ:GCTLong
by Richtv_official
1
🍔📈 Shake Shack (SHAK) Analysis 🌍🔍Strong Performance: Shake Shack NYSE:SHAK , a growing restaurant chain, ended 2023 on a high note with successful sales strategies and margin expansion. CEO Randy Garutti highlighted the opening of 41 new U.S. restaurants and 44 international locations, including in Thailand and the Bahamas. Despite inflationary pressures, same-store sales saw a 2.8% year-over-year increase. Expansion Potential: With the Federal Reserve potentially maintaining or lowering interest rates, Shake Shack could see further expansion in 2024. With 518 locations (334 in the U.S.) at the end of 2023, there is significant growth potential. While it may not reach the size of McDonald's, it could approach Five Guys' nearly 1,500 U.S. locations, potentially quadrupling its current count. Investment Outlook: Bullish Outlook: We are bullish on SHAK above the $87.00-$88.00 range. Upside Potential: With an upside target set at $145.00-$150.00, investors should monitor sales growth and expansion efforts as key performance drivers. 📊🍔 Keep a close watch on Shake Shack's growth for promising investment opportunities! #SHAK #RestaurantGrowth 🌍📈
NYSE:SHAKLong
by Richtv_official
ELI LILLY Preparing for the final buy opportunity.Eli Lilly is on a very steady bullish technical outlook on the 1D timeframe (RSI = 62.145, MACD = 9.380, ADX = 18.580) as it has been trading inside a Channel Up since January 2023. The current bullish vessel within this pattern is a Rising Wedge. As you can see, the two Wedges prior have a last break under the 1D MA50 before rallying to a HH at the top of the Channel Up. The 1D RSI has already crossed over its LH trendline so every pullback that comes in the next 2 weeks, is in our opinion the last buy opportunity. Our target is approximatelly a +45% rise (TP = 1000) which is the rise that all bullish structures prior experienced. See how our prior idea has worked out: ## If you like our free content follow our profile to get more daily ideas. ## ## Comments and likes are greatly appreciated. ##
NYSE:LLYLong
by InvestingScope